Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Dental Caries | 3 | 2018 | 163 | 1.73 | Why? |
| Mouth Neoplasms | 8 | 2021 | 463 | 1.66 | Why? |
| Head and Neck Neoplasms | 8 | 2019 | 1568 | 1.41 | Why? |
| Dentin | 2 | 2017 | 19 | 1.39 | Why? |
| Microscopy | 4 | 2021 | 414 | 1.35 | Why? |
| Dental Pulp | 2 | 2017 | 48 | 1.32 | Why? |
| Mouth Diseases | 4 | 2020 | 193 | 1.01 | Why? |
| Low-Level Light Therapy | 3 | 2020 | 129 | 0.95 | Why? |
| Stomatitis | 2 | 2020 | 57 | 0.91 | Why? |
| Palatal Obturators | 1 | 2020 | 10 | 0.88 | Why? |
| Maxillofacial Prosthesis | 1 | 2020 | 11 | 0.88 | Why? |
| Dental Enamel | 2 | 2017 | 16 | 0.87 | Why? |
| Oral Ulcer | 3 | 2020 | 70 | 0.83 | Why? |
| Diphosphonates | 2 | 2018 | 121 | 0.80 | Why? |
| Cracked Tooth Syndrome | 1 | 2018 | 5 | 0.76 | Why? |
| Carcinoma, Squamous Cell | 5 | 2018 | 902 | 0.75 | Why? |
| Matrix Metalloproteinase 20 | 1 | 2017 | 1 | 0.71 | Why? |
| Tooth Cervix | 1 | 2017 | 1 | 0.71 | Why? |
| Dental Cementum | 1 | 2017 | 8 | 0.69 | Why? |
| Periodontal Ligament | 1 | 2017 | 14 | 0.69 | Why? |
| Matrix Metalloproteinase 2 | 1 | 2017 | 85 | 0.67 | Why? |
| Tooth | 1 | 2017 | 42 | 0.66 | Why? |
| Matrix Metalloproteinase 9 | 2 | 2017 | 211 | 0.65 | Why? |
| Pathology | 1 | 2019 | 121 | 0.64 | Why? |
| Tongue | 1 | 2017 | 132 | 0.61 | Why? |
| Bone Density Conservation Agents | 1 | 2018 | 209 | 0.61 | Why? |
| Image Interpretation, Computer-Assisted | 2 | 2021 | 665 | 0.61 | Why? |
| Radiation Injuries | 1 | 2017 | 140 | 0.60 | Why? |
| Dysgeusia | 1 | 2020 | 524 | 0.57 | Why? |
| Critical Pathways | 1 | 2020 | 1587 | 0.40 | Why? |
| Eosinophilia | 1 | 2013 | 292 | 0.39 | Why? |
| Multiple Myeloma | 1 | 2018 | 1064 | 0.36 | Why? |
| Observer Variation | 3 | 2021 | 622 | 0.35 | Why? |
| Mouth Mucosa | 2 | 2020 | 323 | 0.33 | Why? |
| Immunohistochemistry | 7 | 2018 | 2275 | 0.32 | Why? |
| Maxillary Neoplasms | 1 | 2021 | 21 | 0.23 | Why? |
| Mandibular Reconstruction | 1 | 2020 | 14 | 0.22 | Why? |
| Dental Prosthesis Design | 1 | 2020 | 26 | 0.22 | Why? |
| Mandible | 2 | 2018 | 72 | 0.22 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.22 | Why? |
| Pathology, Oral | 1 | 2020 | 20 | 0.22 | Why? |
| Carcinoma in Situ | 1 | 2021 | 58 | 0.21 | Why? |
| Lasers, Gas | 1 | 2019 | 21 | 0.20 | Why? |
| Telepathology | 1 | 2021 | 115 | 0.20 | Why? |
| Esthetics | 1 | 2020 | 136 | 0.20 | Why? |
| Salivary Glands | 1 | 2020 | 122 | 0.19 | Why? |
| Neuroectodermal Tumor, Melanotic | 1 | 2018 | 2 | 0.19 | Why? |
| Tooth Socket | 1 | 2018 | 9 | 0.19 | Why? |
| Radiography, Panoramic | 1 | 2018 | 26 | 0.19 | Why? |
| Radiotherapy Dosage | 2 | 2017 | 428 | 0.19 | Why? |
| Histiocytosis, Langerhans-Cell | 1 | 2018 | 46 | 0.18 | Why? |
| Photography, Dental | 1 | 2017 | 1 | 0.18 | Why? |
| Dental Cements | 1 | 2017 | 4 | 0.18 | Why? |
| Cherubism | 1 | 2017 | 1 | 0.18 | Why? |
| Fiber Optic Technology | 1 | 2018 | 71 | 0.18 | Why? |
| Paracoccidioidomycosis | 1 | 2018 | 28 | 0.18 | Why? |
| MutS Homolog 3 Protein | 1 | 2017 | 1 | 0.18 | Why? |
| Composite Resins | 1 | 2017 | 16 | 0.18 | Why? |
| Orthodontics | 1 | 2020 | 122 | 0.18 | Why? |
| MutS Homolog 2 Protein | 1 | 2017 | 10 | 0.18 | Why? |
| Jaw Neoplasms | 1 | 2017 | 13 | 0.18 | Why? |
| Ameloblastoma | 1 | 2017 | 14 | 0.17 | Why? |
| Biopsy | 4 | 2021 | 2811 | 0.17 | Why? |
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 2017 | 27 | 0.17 | Why? |
| In Vitro Techniques | 2 | 2018 | 1027 | 0.17 | Why? |
| Taste Buds | 1 | 2017 | 25 | 0.17 | Why? |
| Tooth Extraction | 1 | 2017 | 36 | 0.17 | Why? |
| Skull | 1 | 2017 | 48 | 0.17 | Why? |
| Cell Cycle Checkpoints | 1 | 2017 | 126 | 0.17 | Why? |
| Health Services Accessibility | 1 | 2020 | 10697 | 0.16 | Why? |
| Periodontitis | 1 | 2018 | 171 | 0.16 | Why? |
| Prostheses and Implants | 1 | 2017 | 116 | 0.15 | Why? |
| Diagnosis, Differential | 5 | 2021 | 7220 | 0.15 | Why? |
| Cell Cycle Proteins | 1 | 2018 | 297 | 0.15 | Why? |
| Photochemotherapy | 1 | 2021 | 297 | 0.15 | Why? |
| Carcinoma | 1 | 2018 | 256 | 0.14 | Why? |
| Hodgkin Disease | 1 | 2017 | 204 | 0.14 | Why? |
| Sarcoma | 1 | 2018 | 290 | 0.14 | Why? |
| Immunoenzyme Techniques | 1 | 2017 | 448 | 0.14 | Why? |
| Pathology, Molecular | 1 | 2018 | 343 | 0.14 | Why? |
| DNA-Binding Proteins | 1 | 2017 | 469 | 0.13 | Why? |
| Tuberculosis, Oral | 1 | 2013 | 1 | 0.13 | Why? |
| Workflow | 2 | 2021 | 2373 | 0.13 | Why? |
| Cell Adhesion Molecules | 1 | 2017 | 472 | 0.13 | Why? |
| Granuloma, Pyogenic | 1 | 2013 | 11 | 0.13 | Why? |
| Ki-1 Antigen | 1 | 2013 | 25 | 0.13 | Why? |
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 502 | 0.13 | Why? |
| Muscle Fibers, Skeletal | 1 | 2013 | 31 | 0.13 | Why? |
| Face | 1 | 2017 | 301 | 0.13 | Why? |
| Ageusia | 1 | 2021 | 918 | 0.13 | Why? |
| CD8 Antigens | 1 | 2013 | 72 | 0.12 | Why? |
| Tongue Diseases | 1 | 2013 | 41 | 0.12 | Why? |
| Tongue Neoplasms | 1 | 2013 | 54 | 0.12 | Why? |
| Lymphoma | 1 | 2018 | 522 | 0.12 | Why? |
| Antigens, CD20 | 1 | 2013 | 105 | 0.12 | Why? |
| Infusions, Intravenous | 1 | 2017 | 1224 | 0.12 | Why? |
| Fibroblasts | 1 | 2017 | 839 | 0.12 | Why? |
| Hyperplasia | 1 | 2013 | 204 | 0.12 | Why? |
| Granzymes | 1 | 2013 | 197 | 0.12 | Why? |
| Biomarkers, Tumor | 2 | 2018 | 1314 | 0.12 | Why? |
| Taste Disorders | 2 | 2021 | 1720 | 0.12 | Why? |
| Humans | 37 | 2021 | 930598 | 0.12 | Why? |
| Neoplasms | 2 | 2020 | 17251 | 0.12 | Why? |
| CD3 Complex | 1 | 2013 | 237 | 0.12 | Why? |
| Peroxidase | 1 | 2013 | 207 | 0.12 | Why? |
| Lymphoproliferative Disorders | 1 | 2013 | 110 | 0.11 | Why? |
| Brazil | 6 | 2018 | 12582 | 0.11 | Why? |
| Physical Examination | 1 | 2017 | 755 | 0.11 | Why? |
| Retrospective Studies | 10 | 2018 | 105322 | 0.11 | Why? |
| Neoplasm Recurrence, Local | 1 | 2018 | 1063 | 0.11 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1014 | 0.11 | Why? |
| Male | 21 | 2020 | 367725 | 0.10 | Why? |
| Disease Progression | 3 | 2018 | 13580 | 0.10 | Why? |
| Neoplasm Staging | 1 | 2017 | 1999 | 0.10 | Why? |
| Necrosis | 1 | 2013 | 532 | 0.10 | Why? |
| Dental Care | 1 | 2017 | 795 | 0.10 | Why? |
| Predictive Value of Tests | 3 | 2021 | 9537 | 0.10 | Why? |
| Mast Cells | 1 | 2013 | 370 | 0.10 | Why? |
| Middle Aged | 13 | 2018 | 270681 | 0.10 | Why? |
| Female | 19 | 2021 | 380317 | 0.10 | Why? |
| T-Lymphocytes, Cytotoxic | 1 | 2013 | 552 | 0.09 | Why? |
| Zika Virus | 1 | 2020 | 1924 | 0.08 | Why? |
| Proteomics | 1 | 2018 | 2481 | 0.08 | Why? |
| Zika Virus Infection | 1 | 2020 | 1920 | 0.08 | Why? |
| Eosinophils | 1 | 2013 | 848 | 0.08 | Why? |
| Reproducibility of Results | 2 | 2021 | 11304 | 0.07 | Why? |
| Antineoplastic Agents | 1 | 2020 | 3550 | 0.07 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.06 | Why? |
| Gastrointestinal Diseases | 1 | 2018 | 2580 | 0.06 | Why? |
| Adult | 12 | 2018 | 244371 | 0.06 | Why? |
| Aged | 8 | 2020 | 215776 | 0.05 | Why? |
| Lymphocytes | 1 | 2013 | 3056 | 0.05 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.05 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.05 | Why? |
| Quality of Life | 1 | 2020 | 9820 | 0.05 | Why? |
| Histocytochemistry | 1 | 2018 | 88 | 0.05 | Why? |
| Dental Stress Analysis | 1 | 2017 | 7 | 0.05 | Why? |
| Cathepsin K | 1 | 2017 | 8 | 0.05 | Why? |
| Tissue Array Analysis | 1 | 2018 | 75 | 0.05 | Why? |
| Melanins | 1 | 2018 | 42 | 0.05 | Why? |
| Cyclin D1 | 1 | 2017 | 22 | 0.04 | Why? |
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2017 | 28 | 0.04 | Why? |
| Postoperative Complications | 1 | 2017 | 5861 | 0.04 | Why? |
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 45 | 0.04 | Why? |
| CD56 Antigen | 1 | 2018 | 193 | 0.04 | Why? |
| Tensile Strength | 1 | 2017 | 42 | 0.04 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.04 | Why? |
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 43 | 0.04 | Why? |
| Fibroblast Growth Factor 2 | 1 | 2017 | 77 | 0.04 | Why? |
| Radiography, Abdominal | 1 | 2018 | 88 | 0.04 | Why? |
| Ki-67 Antigen | 1 | 2017 | 139 | 0.04 | Why? |
| Maxilla | 1 | 2017 | 70 | 0.04 | Why? |
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2017 | 127 | 0.04 | Why? |
| Epigenomics | 1 | 2018 | 139 | 0.04 | Why? |
| Remission, Spontaneous | 1 | 2017 | 186 | 0.04 | Why? |
| Lymphatic Metastasis | 1 | 2018 | 537 | 0.04 | Why? |
| Surface Properties | 1 | 2017 | 448 | 0.04 | Why? |
| Receptor, ErbB-2 | 1 | 2017 | 267 | 0.04 | Why? |
| Pilot Projects | 2 | 2018 | 5182 | 0.04 | Why? |
| Prosthesis Failure | 1 | 2017 | 195 | 0.04 | Why? |
| ErbB Receptors | 1 | 2017 | 320 | 0.04 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2017 | 310 | 0.04 | Why? |
| Materials Testing | 1 | 2017 | 380 | 0.04 | Why? |
| Tobacco Use | 1 | 2018 | 340 | 0.03 | Why? |
| Colectomy | 1 | 2018 | 327 | 0.03 | Why? |
| Cross-Sectional Studies | 2 | 2020 | 53120 | 0.03 | Why? |
| Dentistry | 1 | 2021 | 621 | 0.03 | Why? |
| Survival Rate | 2 | 2018 | 9206 | 0.03 | Why? |
| Saliva | 2 | 2020 | 4679 | 0.03 | Why? |
| Adolescent | 6 | 2018 | 86841 | 0.03 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2017 | 1654 | 0.03 | Why? |
| Neoplasm Proteins | 1 | 2017 | 501 | 0.03 | Why? |
| Cell Proliferation | 1 | 2019 | 1973 | 0.03 | Why? |
| Mutation, Missense | 1 | 2017 | 863 | 0.03 | Why? |
| Child | 5 | 2018 | 70012 | 0.03 | Why? |
| Infant | 3 | 2018 | 30274 | 0.03 | Why? |
| Risk Factors | 2 | 2018 | 71621 | 0.03 | Why? |
| Down-Regulation | 1 | 2017 | 1416 | 0.03 | Why? |
| Prognosis | 3 | 2018 | 32490 | 0.02 | Why? |
| Child, Preschool | 3 | 2018 | 36283 | 0.02 | Why? |
| Radiography | 1 | 2017 | 1576 | 0.02 | Why? |
| Papillomavirus Infections | 1 | 2018 | 861 | 0.02 | Why? |
| Clinical Protocols | 1 | 2020 | 2734 | 0.02 | Why? |
| Prevalence | 2 | 2021 | 25773 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2017 | 2830 | 0.02 | Why? |
| Antifungal Agents | 1 | 2018 | 1828 | 0.02 | Why? |
| Age Factors | 2 | 2018 | 21039 | 0.02 | Why? |
| Aged, 80 and over | 2 | 2017 | 88759 | 0.02 | Why? |
| Peptides | 1 | 2018 | 2513 | 0.02 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.02 | Why? |
| Alcohol Drinking | 1 | 2018 | 1663 | 0.02 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.02 | Why? |
| Epithelial Cells | 1 | 2017 | 3508 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2018 | 3755 | 0.02 | Why? |
| Databases, Factual | 1 | 2019 | 6248 | 0.02 | Why? |
| Young Adult | 3 | 2018 | 93724 | 0.01 | Why? |
| Machine Learning | 1 | 2018 | 4395 | 0.01 | Why? |
| Radiography, Thoracic | 1 | 2018 | 5486 | 0.01 | Why? |
| Treatment Outcome | 2 | 2018 | 51732 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.01 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.01 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.01 | Why? |
| Time Factors | 1 | 2018 | 31397 | 0.01 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.01 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.01 | Why? |
Santos-Silva's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(208)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(60)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_